Co‐doping of iron and copper ions in nanosized bioactive glass by reactive laser fragmentation in liquids
Source abstract
Abstract
Abstract Bioactive glass (BG) is a frequently used biomaterial applicable in bone tissue engineering and known to be particularly effective when applied in nanoscopic dimensions. In this work, we employed the scalable reactive laser fragmentation in liquids method to produce nanosized 45S5 BG in the presence of light‐absorbing Fe and Cu ions. Here, the function of the ions was twofold: (i) increasing the light absorption and thus causing a significant increase in laser fragmentation efficiency by a factor of 100 and (ii) doping the BG with bioactive metal ions up to 4 wt%. Our findings reveal an effective downsizing of the BG from micrometer‐sized educts into nanoparticles having average diameters of <50 nm. This goes along with successful element‐specific incorporation of the metal ions into the BG, inducing co‐doping of Fe and Cu ions as verified by energy‐dispersive X‐ray spectroscopy (EDX). In this context, the overall amorphous structure is retained, as evidenced by X‐ray powder diffraction (XRD). We further demonstrate that the level of doping for both elements can be adjusted by changing the BG/ion concentration ratio during laser fragmentation. Consecutive ion release experiments using inductively‐coupled plasma mass spectrometry (ICP‐MS) were conducted to assess the potential bioactivity of the doped nanoscopic BG samples, and cell culture experiments using MG‐63 osteoblast‐like cells demonstrated their cytocompatibility. The elegant method of in situ co‐doping of Fe and Cu ions during BG nanosizing may provide functionality‐advanced biomaterials for future studies on angiogenesis or bone regeneration, particularly as the level of doping may be adjusted by ion concentrations and ion type in solution.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Laser-Ablation Synthesis of Nanoparticles · Bone Tissue Engineering Materials · Laser Applications in Dentistry and Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Technical Chemistry I, University of Duisburg‐Essen and Center for NanoIntegration Duisburg‐Essen, CENIDE Essen Germany
Institute of Biomaterials, Department of Materials Science and Engineering, University of Erlangen‐Nuremberg Erlangen Germany
Funding
China Scholarship Council
References (57)
Show source-provided references
1. 10.1002/jbm.82005061110.1002/jbm.820050611 ↗
2. 10.1021/acsomega.0c0018010.1021/acsomega.0c00180 ↗
3. 10.1021/acsami.5b0900610.1021/acsami.5b09006 ↗
4. 10.1016/j.colsurfb.2019.11034610.1016/j.colsurfb.2019.110346 ↗
5. 10.3390/jfb901002510.3390/jfb9010025 ↗
6. 10.3390/jfb901002410.3390/jfb9010024 ↗
7. 10.1088/1748-6041/8/2/02501110.1088/1748-6041/8/2/025011 ↗
8. 10.1016/j.bioactmat.2020.12.00710.1016/j.bioactmat.2020.12.007 ↗
9. 10.1016/j.cis.2017.03.00810.1016/j.cis.2017.03.008 ↗
10. 10.1016/j.actbio.2013.04.01210.1016/j.actbio.2013.04.012 ↗
11. 10.1007/s11051-012-0966-610.1007/s11051-012-0966-6 ↗
12. 10.1021/acsami.7b0652110.1021/acsami.7b06521 ↗
13. 10.1021/acsabm.0c0029710.1021/acsabm.0c00297 ↗
14. 10.1039/c3tb21007c10.1039/c3tb21007c ↗
15. 10.1111/ijac.1314410.1111/ijac.13144 ↗
16. 10.1007/s10856-009-3789-y10.1007/s10856-009-3789-y ↗
17. 10.1039/C5TB02062J10.1039/C5TB02062J ↗
18. 10.1002/adem.20190157710.1002/adem.201901577 ↗
19. 10.1021/acsami.9b1780110.1021/acsami.9b17801 ↗
20. 10.1002/jbm.b.3493110.1002/jbm.b.34931 ↗
21. 10.1039/c0jm01111h10.1039/c0jm01111h ↗
22. 10.1533/9780857099051.2.17710.1533/9780857099051.2.177 ↗
23. 10.1021/acsami.8b0615410.1021/acsami.8b06154 ↗
24. 10.1021/acsami.8b1908210.1021/acsami.8b19082 ↗
25. 10.3390/nano1002035910.3390/nano10020359 ↗
26. 10.1002/chem.20200068610.1002/chem.202000686 ↗
27. 10.1016/j.actbio.2016.09.01510.1016/j.actbio.2016.09.015 ↗
28. 10.1021/acs.jpcc.8b0437410.1021/acs.jpcc.8b04374 ↗
29. 10.1039/C4CP05740F10.1039/C4CP05740F ↗
30. 10.1016/j.apsusc.2014.07.05310.1016/j.apsusc.2014.07.053 ↗
31. 10.1104/pp.46.6.86210.1104/pp.46.6.862 ↗
32. 10.1007/978-3-658-14171-410.1007/978-3-658-14171-4 ↗
33. 10.1038/s41598-017-13333-z10.1038/s41598-017-13333-z ↗
34. 10.1016/j.apsusc.2016.09.15010.1016/j.apsusc.2016.09.150 ↗
35. 10.1021/acs.jpca.0c0878710.1021/acs.jpca.0c08787 ↗
36. 10.1093/jat/21.2.17210.1093/jat/21.2.172 ↗
37. 10.1007/s00604-020-04454-w10.1007/s00604-020-04454-w ↗
38. 10.1111/ijag.1232310.1111/ijag.12323 ↗
39. 10.1021/cm102889q10.1021/cm102889q ↗
40. The usefulness of chelation therapy for the remission of symptoms caused by previous treatment with mercury‐containing pharmaceuticals: a case report
41. 10.1080/1040843100378823310.1080/10408431003788233 ↗
42. Gradually Fe‐doped Co3O4 nanoparticles in 2‐propanol and water oxidation catalysis with single laser pulse resolution
43. 10.1016/j.ceramint.2017.02.10710.1016/j.ceramint.2017.02.107 ↗
44. 10.3390/ma1306128110.3390/ma13061281 ↗
45. 10.1021/bm100108710.1021/bm1001087 ↗
46. 10.1002/jbm.1020710.1002/jbm.10207 ↗
47. 10.1515/bglass-2019-001110.1515/bglass-2019-0011 ↗
48. 10.1128/AAC.46.6.1940-1945.200210.1128/AAC.46.6.1940-1945.2002 ↗
49. 10.1016/j.msec.2013.05.01210.1016/j.msec.2013.05.012 ↗
50. 10.1016/j.biomaterials.2012.09.06610.1016/j.biomaterials.2012.09.066 ↗
51. 10.1016/j.actbio.2016.03.01110.1016/j.actbio.2016.03.011 ↗
52. 10.1002/jbm.a.3728910.1002/jbm.a.37289 ↗
53. 10.1016/j.mtbio.2020.10004110.1016/j.mtbio.2020.100041 ↗
54. 10.1039/C9TB00820A10.1039/C9TB00820A ↗
55. 10.1023/A:100891071844610.1023/A:1008910718446 ↗
56. 10.1016/j.actbio.2015.03.00910.1016/j.actbio.2015.03.009 ↗
57. 10.5772/6326610.5772/63266 ↗